Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology

| By DM Lloyd-Jones, LT Braun, CE Ndumele et al.

Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial

Clinical Trial | By Ferencik M, Mayrhofer T, Bittner DO et al.

Coronary Atherosclerotic Precursors of Acute Coronary Syndromes

Original Research | By Chang HJ, Lin FY, Min JK et al.

Can Biomarkers of Myocardial Injury Provide Complementary Information to Coronary Imaging?

Expert Opinion | By LJ Shaw, JK Min, Y Chandrashekhar.

Heart Failure and Atrial Fibrillation, Like Fire and Fury

Review Article | By MA Carlisle, M Fudim, AD DeVore et al.

Drug-Coated Balloons: A Safe and Effective Alternative to Drug-Eluting Stents in Small Vessel Coronary Artery Disease

Review Article | By Sinaga DA, Ho HH, Watson TJ et al.

Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review

Review Article | By Mohiaddin H, Wong TDFK, Burke-Gaffney A et al.

Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial

Original Research | By Buiten RA, Ploumen EH, Zocca P et al.

Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial

Original Research | By SS Anand, JW Eikelboom, COMPASS Trial Investigators.

Dual Antiplatelet TherapyIs It Time to Cut the Cord With Aspirin?

Editorial | By KM Ziada; DJ Moliterno et al.